Author Oettle, H.
-
2019 | Journal Article |
Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial
Wittel, U. A.; Lubgan, D.; Ghadimi, M. ; Belyaev, O.; Uhl, W.; Bechstein, W. O. & Grützmann, R. et al. (2019)
BMC Cancer, 19(1). DOI: https://doi.org/10.1186/s12885-019-6148-5
Details DOI
-
2020 | Journal Article
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results
Sinn, M.; Liersch, T. ; Riess, H.; Gellert, K.; Stübs, P.; Waldschmidt, D. & Lammert, F. et al. (2020)
European Journal of Cancer, 138 pp. 172-181. DOI: https://doi.org/10.1016/j.ejca.2020.06.032
Details DOI
-
2020 | Journal Article |
R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial
Fietkau, R.; Grützmann, R.; Wittel, U. A.; Croner, R. S.; Jacobasch, L.; Neumann, U. P. & Reinacher-Schick, A. et al. (2020)
Strahlentherapie und Onkologie, 197(1) pp. 8-18. DOI: https://doi.org/10.1007/s00066-020-01680-2
Details DOI